We hypothesized that COX-2 inhibitors do not decrease COX-2 expression at the cellular level in cancer cells, but rather that COX-2 inhibition induces apoptosis in cancer cells positive for COX-2, and higher COX-2 expression could be associated with a higher proapoptotic effect. This evidence concerns the gene PTGS2 and cancer.